Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients
- 29 February 1996
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 32 (2), 231-234
- https://doi.org/10.1016/0959-8049(95)00568-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosisBritish Journal of Cancer, 1992
- Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancerInternational Journal of Cancer, 1991
- c-erbB-2 oncogene as a prognostic marker in breast cancerBritish Journal of Cancer, 1991
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.Molecular and Cellular Biology, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Amplification of a Novel v- erb B-Related Gene in a Human Mammary CarcinomaScience, 1985
- Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblastsNature, 1981